NCT00272090View on ClinicalTrials.gov

Insulin Glargine in Type 1 Diabetes Mellitus

PHASE3CompletedINTERVENTIONAL

Enrollment

489

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG

Insulin glargine

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY

NCT00272090 - Insulin Glargine in Type 1 Diabetes Mellitus | Biotech Hunter | Biotech Hunter